Conatus Pharmaceuticals Inc. buy melinda
Start price
06.02.17
/
50%
€43.48
Target price
30.03.17
€49.61
Performance (%)
5.62%
End price
30.03.17
€45.92
Summary
This prediction ended on 30.03.17 with a price of €45.92. With a performance of 5.62%, the BUY prediction by melinda for Conatus Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Conatus Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
folgen
Leberhepatitis
(Vom Mitglied beendet)
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.46
02.04.19
02.04.19
€19.84
30.10.19
30.10.19
-79.93%
30.10.19
30.10.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€35.45
06.12.17
06.12.17
€36.98
08.12.17
08.12.17
4.83%
08.12.17
08.12.17